Cardiovascular Business: Why Cardiologists Should Pay Close Attention to Rehospitalizations After TAVR or SAVR

Rehospitalization after aortic valve replacement (AVR) is associated with an increased risk of patient mortality, according to new findings published in the Circulation: Cardiovascular Interventions. This suggests that researchers should continue tracking rehospitalization rates for patients who undergo transcatheter aortic valve replacement (TAVR) or surgical aortic valve replacement (SAVR) going forward.

“Recently, heart failure hospitalizations (HFHs) and composite end points including HFHs, valve-related or procedure-related events have taken on increased importance as endpoints in trials of structural heart interventions,” wrote first author Chetan P. Huded, MD, MSc, a cardiologist with Saint Luke’s Mid America Heart Institute in Kansas City, Missouri, and colleagues. “However, the prognostic importance of rehospitalizations in these patients after AVR remains uncertain. Specifically, it is unclear whether these are transient events or whether they are important markers that identify patients who are at higher risk for worse long-term outcome.”

Read the full Cardiovascular Business article: Why Cardiologists Should Pay Close Attention to Rehospitalizations After TAVR or SAVR

Related Content

Sep. 20, 2022

Healio: Changes in Devices, Procedures Major Driver of Improvement in TAVR Outcomes
Changes in devices and procedural care were the biggest factor in improvements in short-term outcomes for patients undergoing transcatheter aortic valve replacement.
Sep. 20, 2022

TCTMD: Mix of Patient, Procedural, and Device Factors All Drove TAVI Advances
As TAVI outcomes have improved over the years, different factors seem to be driving changes in short-term complications and mortality.
Nov. 9, 2021

tctMD: SURTAVI: Self-Expanding TAVI Valve Holds Up vs SAVR Through 5 Years
After 2 years, clinical outcomes were similar, hemodynamics favored TAVI, and paravalvular leak favored surgery.